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INTRODUCTION 
 
 Preeclampsia is pregnancy specific syndrome that can affect 
virtually every organ system, characterized by hypertension and 
proteinuria in pregnant women with no prior incidence of these sequences 
which remits after delivery. Appearance of proteinuria remains an 
important objective diagnostic criterion.  
 
Criteria for diagnosis of preeclampsia: 
1) Systolic blood pressure of 140mmHg or higher and diastolic blood 
pressure of 90mmHg or higher that occurs after 20wks of gestation 
in a women with previously normal BP. 
2) Proteinuria defined as urinary excretion of 0.3g protein or higher in 
a  24hrs urine specimen. 
 
 PE associated with abnormal or deficient placentation leading to 
increased vascular resistance and reduced placental perfusion. These 
changes are due to endothelial dysfunction. However the factor that cause  
the disturbance has not been identified. 
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 In normal pregnancy, there will be increased fasting plasma insulin 
level, especially maximum in third trimester. Probably due to increased 
amount of several insulin antagonistic hormones such as Human placental 
lactogen,1,2 progesterone3 and Carticotrophin releasing hormones4. 
 
 Insulin is a polypeptide hormone secreted by β-cells of pancreas. 
Insulin formed after elimination of C peptide by hydrolysis. It is made up 
of 2 chains of 21 & 30 AA connected by 2 disulfide bridges. 
 
 The pregnancies complicated by hypertension; there is an 
exaggeration of Insulin resistance and associated metabolic changes. 
 
 Cardiovascular research showed that there is increased evidence 
suggestive of hyperinsulinemia can causes increased endothelial damage 
resulting in atherosclerotic changes in the vessels. 
 
 The aim of the study to test hypothesis that fasting plasma insulin 
levels are increased in women with preeclampsia as compared to 
normotensive women. 
  
Aim & objectives  
of the study 
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OBJECTIVES OF THE STUDY 
 
1. To compare the levels of Fasting plasma insulin levels in 
preeclampsia women and normotensive pregnant women. 
2. To assess the elevation of fasting plasma insulin levels in relation 
to the severity of preeclampsia. 
 
  
Review of Literature 
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REVIEW OF LITERATURE 
 
Preeclampsia is syndrome of endothelial dysfunction, that can 
affect any organ system. The disease may also be associated with a 
variety of other signs and symptoms such as leg edema, visual 
disturbances, vomiting, headache ,right hypochondriac and epigastric 
pain. 
 
Preeclampsia characterized by hypertension, proteinuria7 and 
activation of the hemostatic system which regress after delivery. It is one 
of the most major cause of maternal, perinatal morbidity and mortality. 
 
This is a disorder of multiorgan system that can affect virtually 
every organ and system in the body. It is representation of complex 
disease process involving  nearly the entire system of our body. 
 
This is  most commonly seen in primigravidas and resolves within 
several days after delivery. The exact etiology of the disease is not 
known, although a numerous studies have been put forward. 
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Endothelial cell injury5,6 and altered endothelial cell function 
appears to play an important role in the pathogenesis of all aspects of the 
multisystem damage8 as seen in preeclampsia. Preeclamptic women 
having hyperinsulin that is reflected by higher plasma insulin level 
compared to normal pregnant women. It was hypothesized that 
hyperinsulinemia contributes to the pathogenesis of the disease by 
exerting its effects on glomerular filtration rate, Renal blood flow , 
Plasma aldosterone concentration and urinary sodium exertion. Fasting 
plasma insulin levels were higher in the women during their early third 
trimester which was commonly associated with increased risk of 
preeclampsia. The study results suggested that insulin resistance and 
associated hyperinsulinemia plays a pivotal role in the pathogenesis of 
hypertension complicating  pregnancy. 
 
Classification of Hypertension in pregnancy: 
 The incidence of hypertensive disorders in pregnancy varies 
between 5-10% and it is in raising trend since women are postponing 
their first pregnancy to a later age and increased pre-pregnancy weight. 
High blood pressure is a sign not a disease and it reflects an increase in 
cardiac output or more commonly increased peripheral resistance. 
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 Various schemes of classifying hypertensive disorders in 
pregnancy have been proposed by different obstetric and hypertension 
societies. 
 
 The National Institute of Health (NIH) working group of the 
NHBPEP – National High Blood Pressure education programme (2000)8 
categorized hypertensive disorders into five types. 
 
I. Gestational Hypertension: 
 BP > 140/90mmHg for the first time in pregnancy after 20 weeks 
of gestation. 
 BP returns to normal within 3 months after delivery. 
 There is no proteinuria 
 Patient might have other signs of preeclampsia like headache or 
thrombocytopenia. 
 
II. Preeclampsia (New Hypertension and Quantified Proteinuria) 
1. Basic (Least Criteria) 
o BP -140/90 mmHg or more after 20 weeks gestation  
o Proteinuria ≥ 300mg/24hrs or  persistent 1+ or more  on 
dipstick random sample 
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2. Definitive Criteria 
o BP > 160/110mmHg 
o Proteinuria 2+ on dipstick or 2 gm in 24 hrs urine 
o Raised Serum Creatinine (>1.2mg/dl) 
o Platelets <100000/mm3 
o Microangiopathic hemolysis – increased LDH 
o Elevated liver enzymes – AST and ALT 
o Persistant headache or other cerebral or visual disturbance 
o Persistantepigastric pain 
 
III. Eclampsia 
 Development of convulsion in case of preeclampsia in  the absence 
of other causes of convulsions. 
 
IV. Superimposed preeclampsia on chronic hypertension 
 New onset proteinuria ≥ 300 mg/24hrs in hypertensive women 
but no proteinuria before 20 weeks gestation. 
 A sudden increase in blood pressure or proteinuria or 
thrombocytopenia (Platelet count <100000/mm3) in women 
with hypertension and proteinuria before 20 weeks of gestation. 
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V. Chronic Hypertension 
 Bp>140/90 mmHg before pregnancy or diagnosed before 20 
weeks gestation in absence of gestational trophoblastic disease. 
 Hypertension first diagnosed after 20 weeks but persisting after 
12 weeks post partum. 
 
 
Incidence8,9 
 Gestational hypertension – 5% 
 Preeclampsia – 5-10% of all pregnancies 
 Eclampsia – 0.5-2% 
 Superimposed preeclampsia on chronic hypertension – 25% 
 Hypertension – 1-2% 
 
 
Characteristics Mild preeclampsia Severe Preeclampsia 
Symptoms 
1. Epigastric or upper 
abdominal pain 
Nil Present 
2. Headache Nil Present 
3. Convulsion Nil May be present 
4. Visual or cerebral 
disturbances 
Nil Present 
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Signs 
1. Systolic BP <160mmHg >160mmHg 
2. Diastolic BP <110mmHg >110mmHg 
3. Oliguria Absent Present 
4. Fetal growth 
restriction 
Absent Present 
5. Brisk tendon 
reflexes or clonus 
Absent Present 
6. Cardiac 
dysfunction with 
pulmonary edema 
Absent Present 
Investigations 
1. Proteinuria Trace to 1+ 2+ or more 
2. Platelet Count Normal 
Decreased 
(<100000/mm3) 
3. Evidence of 
hemolysis 
Absent Present 
4. Elevated serum 
transaminase levels 
(AST, ALT) 
Absent Present 
5. Serum creatinine Normal Raised 
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RISK FACTORS FOR PRE-ECLAMPSIA10 
1) Age and Parity: 
a. Nulliparity 
b. Long inter pregnancy interval 
c. Extremes of age (Teenage pregnancy / Pregnancy >40yrs) 
 
2) Genetic predisposition 
a. Family history of preeclampsia 
b. Race and ethinicity – preeclampsia more common in blacks 
and Asians. 
 
3) Secondary to underlying disorders 
a. Diabetes Mellitus 
b. Renal disease 
c. Chronic hypertension 
d. Obesity (BMI >35kg/m2) 
e. Collagen vascular disorders 
f. Hyperhomocysteinemia 
g. Antiphospholipid antibodies 
h. Factor V Leiden deficiency 
i. Protein C and S deficiency 
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4) Pregnancy related risk factors 
a. Molar pregnancy 
b. Hydropsfetalis 
c. Multiple pregnancy 
d. UTI 
 
5) Partner – related factors 
a. Donor insemination 
b. Limited exposure to sperm 
c. Partner changing 
 
ETIOLOGY 
 Preeclampsia is a multifactorial disorder. The exact etiology 
remains unknown. Numerous non mutually exclusive hypothesis have 
been explored some of the accepted hypothesis of etiopathogenesis 
include: 
i) Abnormal trophoblastic invasion and placental ischemia theory 
ii) Immunological theory11 
iii) Genetic imprinting12 
iv) Nutritional factors13-16 
v) Vascular and inflammatory changes due to maternal 
maladoptation17,22,23,24 
12 
 
vi) Intervention of various factors 
vii) Endothelial cell activation17-21 
 
Preeclampsia during pregnancy occurs more often; 
a) In women exposed to the chorionic villi for the first time; 
b) In women exposed to excess of chorionic villi. (e.g. Multiple 
pregnancy and hydatidifrom mole). 
c) Have preexisting renal or cardiovascular disease 
d) Genetically predisposed women 
 
 Several recent studies showed that insulin resistance many also 
play a role in pathogenesis of preeclampsia and suggest parallels  
between preeclampsia and insulin resistance. 
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(ET -1- Endothelin -1, PIGF- Placental Growth factor, ROS- Reactive 
Oxygen species, SFLT- 1- Soluble Fms like Tyrosine Kinase-1, VEGF- 
Vascular Endothelial Growth Factor) 
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1. Abnormal trophoblastic invasion and placental ischemia theory 
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 The uterine spiral arterioles undergo extensive changes during 
pregnancy as they are invaded by endovascular trophoblasts. These cells 
replace the vascular endothelial lining to increases diameter of vessel in 
case of normal implantation. In preeclampsia; however there may be 
incomplete trophoblastic invasion of decidual vessels, but not myometrial 
vessels and their mean diameter is only half that of vessels in normal 
placentas. Abnormally narrow spiral arteriolar lumen impairs placental 
blood flow. The decreased placental perfusion and hypoxic environment 
leads to placental debris. That incites a systemic inflammatory response 
in patients with preeclampsia. 
 
2) Immunological theory:11 
 Normal placentation required a balance between maternal immune 
response and fetal allograft. Hence these balance might be disturbed in 
case of preeclampsia thus the endovascular trophoblastic invasion of 
spiral arteries in the myometrial segment does not occur resulting in 
fetoplacentalhypoperfusion in later stages of pregnancy. 
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 Past exposure to paternal antigen (fetal cells and placenta) is 
protective against preeclampsia which explains higher incidence of 
preeclampsia in primigravidas and in pregnancies on change of partner or 
on donated sperm. 
 
 Some examples of inherited immunogenetic factors that many 
modify phenotype and genotype expression in preeclampsia. 
a) Immunization from prior gestation 
b) Inherited haplotypes for NK cells receptors – also called 
killer – immunoglobulin like receptor. 
c) Inherited haplotypes for HLA-A, B, D, Ia, II 
d) Possibly shared susceptibility genes with chronic 
hypertension and diabetes. 
 
A study recently reviewed the possible role of immune 
maladaptation in pathophysiology of preeclampsia. Right from early 
second trimester, women who expected to develop preeclampsia have a 
significantly lower proportion of helper ‘T’ cells (Th1) compared with 
that of women who remains normotensive. 
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3) Genetic Imprinting:12 
 Preeclampsia is a polygenic and multifactorial disorder. The 
predisposition to hereditary hypertension might be linked to preeclampsia 
and the tendency for preeclampsia-eclampsia has been initiated.  
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Genetic predisposition can be involved in 
- Single recessive gene with a frequency of 0.25 
- Genes involved in placental vascular injury / blood pressure 
regulation / placental vascular remodeling such as. 
o TNF-αgene (Tumour necrosis factor – alpha gene) 
o ET-1gene (Endothelin-1 gene) 
o Ag 1 gene(Angiotensinogen gene - T235) 
o E-Nos gene (Endothelial Nitric oxide synthetase gene) 
20 
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4) Nutritional Factors:13-16 
 Dietary  excess or deficiency have been blamed as the cause of 
preeclampsia. However dietary taboos that have been implicated in 
association with preeclampsia are diary products, meat, protein, purines, 
fat, salts and other elements. 
 
5) Vascular and inflammatory changes due to maternal 
 maladaptation17,22,23,24 
 Placental ischemic changes associated with increased level of 
cytokines and interleukin levels which play as a oxidative stress22 marker 
associated with preeclampsia. The following oxidative stress markers25,26 
found to be increased in preeclampsia such as 
a) Malonyldialdehydes 
b) Glutathione peroxides 
c) Superoxide dismutase 
 
Antioxidants  have been found to be reduced in 
a) Lycopene 
b) Vitamin C 
22 
 
 
 
6) Endothelial cell Activation: 17-21 
 It has been proposed that endothelial cell dysfunction17 is due to an 
extreme activated state of leukocytes in the maternal circulation. 
 
 Normal maternal vascular endothelium lined by single squamous 
epithelium which covers the luminal side of blood vessels respond to 
relaxing and contracting factors which maintains vascular hemostasis. 
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 Cardiovascular research showed with increased evidence that 
hyperinsulinemia can cause endothelial dysfunction which leads to 
increase in the formation of endothelial and thromboxane which increases 
sensitivity of vascular endothelium to angiotensin II and decreased the 
level of prostacyclin (Vasodilator). 
 
- It has been hypothesized that hyperinsulinemia contributes to the 
pathogenesis of the disease by its effects on urinary Na+ excretion, 
Glomerular filtration rate, Renal blood flow and plasma 
aldosterone concentration. 
 
- There is a functional imbalance18 between vasodilator and 
vasoconstrictor in preeclampsia. 
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PATHOPHYSIOLOGY OF PREECLAMPSIA 
 It is a dynamic and progressive process. It is a syndrome with 
multiorgan system involved with adverse fetal and maternal effects. All 
mechanism are interrelated provide positive feed back leading to further 
vascular damage. Thus establishing a visious cycle. 
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PATHOGENESIS 
1) VASOSPASM: 
 Vasospasm plays a crucial role in pathogenesis of preeclampsia – 
eclampsia and is based upon the direct observation of small blood vessels 
in the nail beds, ocular fundi and bulbar conjunctiva. It also shows 
histological changes in various organ system. Generalised vascular 
constriction leads to increased vascular resistance to blood flow  which 
lead on to hypertension.   
                                                Vasospasm 
 
Increased resistance to blood flow 
 
Endothelial damage 
 
Inter endothelial leaks through which blood constituents,  platelets and 
fibrinogen are deposited sub endothelially 
 
Ultra structural changes in the sub endothelial region of resistance vessels 
 
Diminished blood flow 
 
Ischemia of surrounding tissues 
 
End organ disturbance 
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2.INCREASED PRESSOR RESPONSE:18 
 Normal pregnant women develops refractoriness to vasopressor 
agents. The refractoriness in normal pregnancy is due to the 
downregulation of the angiotensin receptors present in the vascular 
smooth muscle. There is evidence support that abalance between the 
production and metabolism of the vasoactive prostoglandin is responsible 
for maintenance of  vascular refractoriness. 
 
 Moreover increased sensitivity to angiotensin II clearly proceeds 
the onset of gestational hypertension. Women with preeclampsia lost this 
refractoriness several weeks before the onset of hypertension. 
 
3.NITRIC OXIDE: 
 The effects of nitric oxide production in preeclampsia is unclear. It 
is a potent vasodilator synthesized from L.Arginine by endothelial cells. 
In normal pregnant women, nitric oxide maintains the normal low 
pressure vasodilated state characteristic of fetoplacental perfusion. 
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Preeclampsia 
 
Decreased endothelial nitric oxide synthase expression 
 
Increasing nitric oxide inactivation 
 
Increases mean arterial  pressure, decrease HR 
 
Reverses the pregnany – induced refractoriness to vasopressors 
 
4.ENDOTHELINS: 
 Endothelins are 21 amino acid peptides are potent vasoconstrictors. 
Endothelin-I 24 produced by human endothelium and have found to be 
increased in preeclampsia. 
 
5.PROSTOGLANDINS: 
 When compared with normal pregnancy; endothelial prostacyclin 
(PGI2) production is decreased, Thromboxane A2 secretion increased. In 
preeclampsia prostacyclin: Thromboxane A2 ratio decreases. The net 
results favors increased sensitivity to angiotensin II resulting in 
vasoconstriction.23 
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PATHOPHYSIOLOGICAL CHANGES 
1) UTEROPLACENTAL INSUFFICIENTLY: 
a) Vasospasm of utero placental vasculature causes intrauterine 
growth restriction, placental infarction, iatrogenic prematurity and 
abruptio placentae. 
 
b) There is premature ageing of placenta and areas of  infarcts seen 
on the maternal surface of placenta on histopathological examination. 
 
2) CARDIOVASCULAR CHANGES 
 Due to generalized vasospasm, the normal hypervolemia of 
pregnancy is not seen in preeclampsia as a result of which there is 
decreased cardiac preload. Cardiac output is decreased because of 
decreased in preload and increased after load. Central venous pressure 
and pulmonary capillary wedge pressure is reduced in preeclamptic 
women. 
 
3) VOLUME HOMEOSTASIS17 : FLUID AND ELECTROLYTE 
CHANGES17 
 Edema in preeclampsia is due to expanded extracellular fluid 
which is possibly due to endothelial injury. Reduced plasma oncotic 
pressure play a important role in these women causes  
infiltrationimbalance causing further displacement of intravascular fluid 
30 
 
into the extravascular space. There is no electrolyte imbalance unless 
there is fluid overload or excessive administration of diuretics. 
 
4) ENDOCRINE CHANGES:17 
 Plasma levels of renin, angiotensin II and aldosterone are reduced 
to non pregnant levels in women with preeclampsia. But their blood 
vessels are more sensitive to their chemical substances. Inspite of 
decrease in aldosterone level, there is increase in the sodium retention. 
 
5) RESPIRATORY CHANGES: 
 a) Pulmonary edema 
 b) ARDS (Adult respiratory distress syndrome) 
 c) Chemical pneumonitis 
d) Scattered alveolar hemorrhages 
e) Pneumonia 
 
6) HAEMATOLOGICAL CHANGES:17 
 Haematological abnormalities develop in some women with 
preeclampsia in the form of 
i) Thrombocytopenia (most common)17 
ii) Microangiopathic hemolytic anemia 
iii) Increased blood viscoscity 
iv) Hemoconcentration 
v) Disseminated intravascular coagulation 
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PROTEINURIA 
 Proteinuria defined as urinary excretion of >150mg of protein / day 
over 24 hours of urine collection. It is due to increased permeability of 
glomerular capillaries to non filtered plasma macromolecules like 
albumin. 
 
 In a normal person the urinary protein excretion will be 
<150mg/day.  Of which  majority  60% consists of Albumin and 40% of 
tubular Tamm Horsfall Protein. 
 
 Proteinuria in pregnancy defined as excretion of urinary protein of 
>300mg/day in 24 hours urine collection.29 
 
 Inspite of all the above explanation, proteinuria in preeclampsia 
represents the severity of disease. The absence of it does not exclude the 
severe form of  preeclampsia.  From  the  reference  reported  that  
eclampsia and severe preeclampsia can occur without proteinuria.30 
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PROTEINURIA: 
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INSULIN:  
 In 1921 Frederick G.Banting and Charles H. Best successfully 
discovered the Insulin. 
 
STRUCTURE
 
 
 Insulin is a large polypeptide hormone consisting of two aminoacid 
(21AA and 30AA) linked by disulfide bonds. Insulin also known as 
hormone of nutrient abundance. 
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INSULIN SYNTHESIS: 
 Insulin gene encodes a large precursor of insulin known as 
preproinsulin, during translation, the signal peptide is cleared into 
proinsulin. While packaging in granules by Golgi this proinsulin is 
cleared into insulin and C-peptide. 
 
DNA (Chromosine 11) in cells 
 
mRNA 
 
Preproinsulin (Signal peptide, A chain, B chain and Peptide C) 
 
Proinsulin 
 
Insulin 
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Metabolic regulation of insulin secretion: 
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Glucose entered into the  cells by Glut-2 carriers this action is 
independent of the presence of insulin 
 
Phosphorylation of glucose by glucokinase 
 
Metabolisation with synthesis 0f  ATP 
 
With increasing ATP closing of ATP dependent K+ channels 
 
Ca2+ entry triggers exocytosis 
 
Secretion of insulin 
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REGULATION OF INSULIN SECRETION: 
Regulators of Insulin Secretion 
Stimulators of Insulin Secretion Inhibitors of Insulin Secretion 
 
 Serum glucose 
 Serum Aminoacids 
 Serum free fatty acids 
 Serum ketone  bodies 
 
Hormones: 
 Gastro inhibitory peptide 
 Glucagon 
 Gastrin 
 Cholecystokinin (CCK) 
 Secretin 
 Vasoactive intestinal peptide 
(VIP) 
 Epinephrine ( receptor) 
 
Parasympathetic nervous system 
 
 
 
 Glucose 
 Aminoacid 
 Free fatty acid 
 
Hormones: 
 Somatostatin 
 Epinephrine (α-receptor) 
 
Sympathetic nervous system 
stimulation 
 
 
Reference – Valve for Insulin Levels 
0.7-25µ units/ml 
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HYPERINSULINEMIA 
 
Genetic Factor Life Style Changes Drugs Pathological 
 
 Ethinicities (American, 
Hispanic, African)  
 Family history with 
Type2 DM 
 Insulin receptor 
mutation (Donohue 
syndrome) 
 LMNA mutation 
(Familial partial 
lipodystrophy) 
 Gestational Diabetes 
Mellitus 
 
 Increasing age 
 Stress 
 Sedentary life style 
 Lack of physical 
exercise 
 Obesity 
 Tobacco smoking 
 Caffine intake 
 Alcohol 
 
 Corticosteroids 
 Progestogens 
 Rifampicin 
 Isoniazid 
 Olanzapine 
 Methadone 
 Anti retrovirals 
 
 Metabolic syndrome 
 Liver pathologies 
 Infection (Hepatitis-C) 
 Haemochromatosis 
 Polycystic Ovarian Syndrome 
 Gastroparesis 
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Insulin Resistance and Normal Pregnancy: 
 Pregnancy is a diabetogenic state  therefore there are high changes 
of metabolic instability of glycemic control can occur in pregnancy. 
However insulin resistance and the resultant hyperinsulinemia are 
characteristic of normal pregnancy and this will be maximal during third 
trimester. This could probably mediated by increasing amounts of several 
insulin antagonistic hormones including human placental lactogen,1,2 
progesterone3 and corticotrophin4 releasing hormone. As a result of this 
peripheral and hepatic insulin resistance develops by second trimester 
despite exaggerated maternal insulin response and increased maternal 
plasma insulin levels. 
 
INSULIN RESISTANCE AND HYPERTENSIVE PREGNANCY: 
 In hypertension complicated pregnancies there will be an 
exaggeration of insulin resistance and the associated metabolic changes. 
Features of Insulin resistance accompanied by preeclampsia includes; 
- Hypertension 
- Obesity 
- Lipid abnormalities 
- Hyperinsulinemia 
- Glucose intolerance 
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- Elevated testosterone 
- Reduced sex hormone binding globulin 
 
 Evidence suggest that insulin resistance is intrinsically linked to 
high blood pressure.31,35 The association between insulin resistance and 
hypertension was first reported in 1966 36 and further enormous clinical 
and epidemiological studies have confirmed it.33,37-50 These studies 
pointout that hypertensives tend to be more hyperinsulinemic  in 
comparison to normotensive individuals. However the relationship 
between the insulin resistance and hypertension is independence of BMI, 
Age and magnitude of glucose tolerance.51 
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 There are several clinical, epidemiological and experimental data 
currently support not only an association but a causal link between insulin 
activity and blood pressure.32,36,52-55 
 
 Several datas have documented hyperinsulinemia in early and mid 
pregnancy before the development of preeclampsia. Exaggerated 
hyperinsulinemia when compared to normal pregnancy56,57 is well 
explained in women with established preeclampsia. 
 
 Decreased levels of sex hormone binding globulin (SHBG) which 
is considered as a marker of hyperinsulinemia has been linked to 
increased incidence of development of preeclampsia complicating 
pregnancy. This is seen as early as 1st trimester. 
 
 Recent studies also indicate that women who had experience 
preeclampsia in their pregnancy may be at increased risk in later life for 
the development of complication associated with insulin resistance which 
include Type-2 Diabetes Mellitus, Hypertension. Dyslipidemia and 
cardiac diseases. 
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PREECLAMPSIA ASSOCIATED WITH HYPERINSULINEMIA  
 In the regulation of blood pressure, the role of insulin remains 
unclear, but several mechanism has been studied, they are 
1. Stimulation of sympathetic nervous system 
2. Retention of sodium 
3. Endothelial dysfunction 
4. Increases sensitivity to vasopressors 
5. Enhance the cation transport 
6. Defects in insulin action 
 
1) Stimulation of sympathetic nervous system: 
 Pregnancy complicated by preeclampsia associated with insulin 
resistance and  hyperinsulinemia  can be understood by insulin activity on 
renal and cardiovascular system. 
 
Hyperinsulinemia 
 
Stimulation of sympathetic system 
 
Increase in catecholamines concentration 
 
Increase in the peripheral vasoconstriction 
 
Elevation of blood pressure 
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2) Retention of sodium:35,59 
 There are several physiological actions of insulin that may either 
directly or indirectly affect the sodium and water balance, vascular 
resistance and cardiac contractility. In normal pregnancy there will be a 
tendency to retain sodium and this physiological phenomenon can be 
aggravated by insulin which is in excess in preeclampsia. Therefore 
insulin has been considered as a regulator of hypertension and an 
intensifier of physiological phenomenon in preeclamptic pregnancy. 
 
3) Endothelial dysfunction:17,18 
 Hyperinsulinemia   causes  endothelial damage by several 
machanism, which is involved in the pathogenesis of preeclampsia. 
 
Endothelial dysfunction 
 
Increase in the formation of endothelin thromboxane 
 
Increased vascular sensitivity to Angiotensin II and decreased formation 
of the vasodilators such as prostacyclin and nitric oxide. 
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4) Increases the Sensitivity to Vasopressors:60-62 
 In preeclampsia there is a defect in insulin action which leads to 
increased vascular tone and enhances the sensitivity to vasopressors such 
as angiotensin and other vasoconstrictor. 
 
5) Enhance the cation transport:32,63-66 
 Several studies has been postulated that insulin may regulate 
intracellular calcium levels and modulate intracellular cation pumps, 
thereby affecting vascular tone and blood pressure. 
 
6) Defects in the insulin action:67-69 
 There are several abnormalities in lipid metabolism especially, 
increased levels of triglyceride, FFA, very low density lipoprotein 
(VLDL), low density lipoproteins (LDL) and decreased levels of high 
density lipoproteins (HDL). These abnormalities has been strongly 
associated with development of preeclampsia.67-69 
 
 Compared to normal pregnancy, preeclampsia associated with 
hyperinsulinemia  which is reflected by high fasting plasma insulin 
levels. It was postulated  that hyperinsulinemia  might contributes to the 
pathogenesis of preeclampsia.80 
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 Bauman et al 22 was first reported the association  between insulin 
levels and hypertension during pregnancy. They documented that 
hypertensive patients were more hyperinsulinemic compared to 
normotensive patients. The levels of hyperinsulinemia in preeclampsia 
were positively correlated with systolic and diastolic blood pressure.  
 
 In this regard “Paretti et al 81 documented that correlation of insulin 
resistance and the fasting insulin level using several insulin sensitivity 
tests will be useful in predicting the development of preeclampsia. There 
is an increased incidence of insulin resistance among women who 
subsequently developed preeclampsia. It postulates that insulin resistance 
might be in causal pathway of preeclampsia. 
 
 Solomon et al,70 reported that higher fasting insulin and cholesterol 
levels in mid trimester are frequently associated with high risk for 
developing pregnancy induced hypertension and study revealed the role 
of insulin resistance in the development of complications during 
pregnancy. 
 
 Defronzo71 documented that the association between 
hyperinsulinemia and hypertension and the study suggested that insulin 
plays a  pivotal role in hypertension observed often in obese subjects 
through its direct effect on the renal sodium retention. 
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 Kaplan74 indicated that hyperinsulinemia and insulin resistance has 
a important role in pathogenesis of preeclampsia. 
 
 Feldman and Bierbrier 72 recently reported that insulin acts as a 
direct vasodilator and they demonstrated the vascular sensitivity to 
insulin similar to the systemic metabolic sensitivity which was decreased 
in hypertensive patients. 
 
Preeclampsia, a pregnancy specific syndrome is known to 
accompanied by metabolic changes similar to insulin resistance 
syndrome. 
 
Kaaja et al 73 reported more recently that women with preeclampsia 
are more hyperinsulinemic than normotensive controls. 
 
Reaven et al31 indicated that hyperinsulinemia and insulin 
resistance may play a vital role in the pathogenesis of syndrome X, which 
is characterized by hyperinsulinemia, insulin resistance, increased levels 
of VLDL, glucose intolerance and hypertension. 
 
Rowe et al58 found that insulin increases the blood pressure by 
increasing the sympathetic tone. 
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Laivori  et al57 suggested that higher fasting insulin levels among 
22 women with preeclampsia comlicated pregnancy as compared with 
normotensive pregnancy. 
 
Fuh et al56 documented in their study that 13 women with 
preeclampsia complicating pregnancy 13 women with normotensive 
pregnancy and 8 weeks postpartum found high insulin levels in the group 
with the history of preeclampsia. 
 
Sowers et al75 reported in its prospective study of 164 
predominantly black women, he noted significantly higher insulin levels 
among women, subsequently developing pregnancy induced hypertension 
as compared to normotensive controls. 
 
Wolf et al indicated that lower sex hormone binding globulin in 
first trimester correlated negatively with insulin resistance and 
hyperinsulinemia in women subsequently developing preeclampsia as 
compared with normotensive pregnancy. 
 
Lasko 82 found that fasting insulin levels used as a marker of 
insulin resistance. 
 
Modan et al84 conducted a large epidemiological study and found a 
strong association between hyperinsulinemia, hypertension and impaired 
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GTT in a random population sample. Several studies conducted recently 
have documented that preeclamptic women, have insulin resistance for 
months after delivery. 
 
Some of the cross sectional studies suggested that women with 
established preeclampsia having higher fasting insulin 75,76 levels and low 
insulin sensitivity than the controls. All together these data indicated that 
insulin resistance may contribute to the pathogenesis of preeclampsia. 
 
Certain studies documented that women with preeclampsia had 
higher fasting insulin level at their second trimester, even before the 
appearance of clinical signs of preeclampsia.70,75,76,78 
 
 In a prospective study conducted on nulliparous women reported 
that an association  between the sex hormone binding globulin  and 
preeclampsia and the study was strengthened among the lean women with 
increased level of SHBG associated with marked decrease in the risk of 
developing preeclampsia. 
 
 Plasma insulin level in a fasting state are measured by using a 
double antibody radioimmunoassay.85 
  
Materials and Methods 
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MATERIALS AND METHODS 
Sample Size: 
 Hundred pregnant women (70 cases and 30 controls) admitted to 
Institute of Obstetrics and Gynaecology, Madras Medical College during 
the study period (September 2014 to July 2015) was enrolled for the 
study, who satisfied the inclusion criteria. 
 
Study type: 
 Comparative Study 
 
Period of Study: 
 10 Months 
 
Method of collection of data: 
 A comparative study was conducted on 100 pregnant women in 
their 3rd trimester who were enrolled in the study based upon the fasting 
insulin level and their correlation with the severity of the disease based on 
their age, parity, gestational age and severity of hypertension was studied. 
 
 After obtaining all proper consent for the study, all the women 
were subjected to detailed history, examination and all were verified for 
the use of iron, folic acid, vitamins and any other drugs. 
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 Besides all routine antenatal investigations and special 
investigations in preeclamptic women all of them were subjected to 
fasting plasma insulin levels. 
 
 Fasting plasma insulin level was measured by taking 3ml of blood 
from the antecubital vein in the fasting state after overnight all the blood 
specimens were transported to the laboratory within 2 hours of collection. 
Then the specimens were centrifuged for 6-8 minutes at 2000rpm. Clear 
serum separated which was stored in a refrigerator until analysis. 
Thereafter the samples were subjected to Chemiluminescent 
Immunoassay (CLIA) technique using the FDA approved reagent and kit. 
 
DATA ANALYSIS: 
Statistical analysis of the collected data was done by; 
- Pearson chi-square test 
- Fischer’s test 
- ‘t’ test 
p<0.05 was taken as statistically significant 
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INCLUSION CRITERIA: 
 After the written and informed consent, pregnant women with 
preeclampsia taken as cases and normotensive pregnant women taken as 
control group all antenatal pregnant women between 26-38 weeks. 
- Hypertensives (cases) 
- Normotensives (control) 
 
EXCLUSION CRITERIA: 
- Diabetes mellitus 
- Chronic hypertension 
- Renal disorder 
- Liver disorder 
- Coagulopathy 
- Collagen vascular disorder 
- Neural tube defect 
 
 
 
 
  
Results 
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RESULTS & ANALYSIS 
 
 
Table 1 : Number of women in the study 
 
Group Number 
Preeclampsia 70 
Normotensive 30 
Total 100 
 
 The current study was conducted on 100 women of which 70 
preeclampsia women were taken as cases, 30 normotensive were taken as 
control. 
 
 
  
70%
30%
Distribution of women in the study
Preeclampsia Normotensive
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Table 2: Severity of Hypertension 
 
Group No % 
Mild Preeclampsia 24 34.3% 
Severe Preeclampsia 46 65.7% 
Total 70 100% 
 
 Based on NHBPEP 2000 classification the cases were further 
classified into mild and severe preeclampsia. Among the cases in the 
study 34.3% (24) were in mild preeclampsia, 65.7% (46) were in severe 
preeclampsia. 
 
 
  
34.3%
65.7%
Distribution of severity of preeclampsia
Mild Preeclampsia Severe Preeclampsia
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Table 3 : Age Distribution 
Age  < 20 Yrs 20-30 yrs >30 yrs Total 
Control 
No 5 17 8 30 
% 45.5% 26.2% 33.3% 30 
Mild 
No 3 19 2 24 
% 27.3% 29.2% 8.3% 24 
Severe 
No 3 29 14 46 
% 27.3% 44.6% 58.3% 46 
Total No 11 65 24 100 
 
X2 = 3.073 p = 0.215 NS 
 
 The mean age of the women in the control group was 26.17 and in 
study group was 27.09 which was comparable with both groups. In this 
study maximum number of women were in the age group between 20-30 
years (65%) in control and study group. The results obtained were 
statistically not significant. 
  
 58 
 
 
Table 4 : Patient Profile 
 
 Age Parity Gestational Age BMI 
Control Group  
N=30 
26.17 
(18-40 yrs) 
Primi 50% 
Multi 50% 
35.17% 
(26-38 wks) 24.53 
Study Group 
N=70 
27.09 
(18-40 yrs) 
Primi 
71.4% 
Multi 
28.6% 
33.41% 
(26-38 wks) 24.83 
 
Table 5 : Parity Distribution 
Parity 
Group 
Total 
Control Study 
Primi 
Count 15 50 65 
% 50% 71.4% 65% 
Multi 
Count 15 20 35 
% 50% 28.6% 35% 
Total 
Count 30 70 100 
% 100% 100% 100% 
 
X2 = 6.992 P=0.030HS 
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 In control group, number of primigravida was 50% and 71.4% in 
the study group, where as the multi’s were 50% in the control group and 
28.6% in study group and the results obtained were statistically 
significant. 
 
 
  
0
10
20
30
40
50
60
70
80
Control Study
50%
71.4%
50%
28.6%
Distribution of women in the study based on their 
parity
Primi
Multi
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Table 6 : Period of Gestation at the time of sampling 
 
Group 26-32 wks 33-38 wks 
Control 5 (16.7%) 25 (83.3%) 
Mild 10 (14.3%) 14 (20%) 
Severe 20 (28.6%) 26 (37.1%) 
 
Fishers exact test  p = 0.008 HS 
 
 
 83.3% women in control group, 57.1% with variable degree of 
preeclampsia were at late trimester at the time of sampling. 
 
 16.7% of women in control and 42.9% of women with 
preeclampsia were at early gestation at the time of sampling. As per 
statistical analysis the period of gestation shows significance. 
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0
10
20
30
40
50
60
70
80
90
26-32 wks 33-38 wks
16.7%
83.3%
14.3%
20%
28.6%
37.1%
Distribution of women in the study based on the 
gestational age at the time of sampling
Control
Mild
Severe
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Table 7 : BMI 
 
 No Mean BMI SD 
Normotensive 30 24.53 2.83 
Mild preeclampsia 24 25.12 2.78 
Severe preeclampsia 46 24.83 2.68 
 
F=0.316  P=0.575 NS 
 
 
 The mean BMI in the normotensive group was 24.5 and in mild 
preeclampsia, severe preeclampsia was 25.12, 24.83 respectively. BMI 
was slightly more in preeclampsia group, possibly due to edema. 
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Distribution of women in the study based on BMI 
  
24.2
24.3
24.4
24.5
24.6
24.7
24.8
24.9
25
25.1
25.2
Control Mild
preeclampsia
Severe
preeclampsia
24.53
25.12
24.83
BMI
BMI
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Table 8  : Fasting insulin level among cases and control 
 
 N Mean SD SE 
Normotensive 30 2.2417 1.84956 0.33768 
Preeclampsia 70 19.9337 11.62100 1.38898 
 
F=164.516    P=0.000 VHS 
  
 
 
 
0
2
4
6
8
10
12
14
16
18
20
Control Case
2.2417
19.9337
Fasting Insulin Level among cases & control
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 In the present study, the mean fasting insulin levels in 
normotensive group was 2.24µunit/ml and in preeclampsia group was 
19.9337µunit/ml. The results obtained indicates that fasting insulin levels 
were high in preeclampsia study group as compared to the normotensive 
control group and the results were statistically significant, p=0.000 vhs. 
 
 
 
Table 9 : Fasting Insulin Level in Various groups 
 
 N Mean SD 
Normotensive 30 2.2417 1.84956 
Mild preeclampsia 24 7.3571 2.30602 
Severe preeclampsia 46 26.4954 8.71688 
 
F=164.516; p=<0.000 
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Distribution of the fasting insulin level among controls and various 
groups of preeclampsia 
 
  
0
5
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Control Mild Severe
2.24
7.36
26.5
Fasting Insulin Level
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 The mean fasting insulin level in control group were 2.24 
µunits/ml, in mild preeclampsia was 7.36 µunits/ml, in severe 
preeclampsia it was 26.50 µunits/ml. However all two groups of cases 
had higher values of fasting insulin levels as compared to normotensives 
(2.24µunits/ml) and difference among each group were statistically 
significant with P=0.000 vhs. 
 
  
Discussion 
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DISCUSSION 
 
 Preeclampsia is a pregnancy specific syndrome which is leading 
cause of maternal and fetal morbidity and mortality. However the exact 
pathogenesis of preeclampsia is still unknown, we have considered that in 
preeclampsia the basic pathophysiology is endothelial dysfunction and 
generalized vasospasm. 
 
 Hyperinsulinemia has been considered as a risk factor for 
peripheral vascular disorder and coronary heart disease. This risk is due 
to the modification of endothelial function as result of exposure to high 
insulin level. 
 
 Although the exact mechanism by which insulin causes endothelial 
dysfunction remains uncertain, but it appears to involve both cytotoxic 
and oxidative stress mechanism is very similar to those hypothesized to 
promote endothelial dysfunction in preeclampsia. However the 
pathogenesis of preeclampsia sharing striking similarities to that of 
artherosclerosis. So that it has been postulated that insulin concentration 
is greater in preeclampsia patient when compared to normotensive 
pregnant patients. 
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Study Normotensive µunits/ml 
Preeclampsia 
µunits/ml P value 
Hamaski T et al 
(1996) 
7.3 
n=551 
24.1 
n=29 P<0.05 
Soloman et al 
(1999) 
7.9 
n=551 
13.3 
n=29 P=0.03 
Chandana Tripathy 
et al (1999) 
6.33 + 2.83 
n=551 
9 + 5 
n=29 P=0.0004 
Shohreh et al 
(2002) 
16.2 + 1.3 
n=16 
25.3 + 1.4 
n=16 P<0.01 
Lei Q et al  
(2008) 
8.92 + 4.4 
n=200 
11.44 + 6.72 
n=33 P=0.005 
Present Study 
(2014) 
2.24 
n=30 
19.9337 
n=70 P<0.000 vhs 
 
 In our present study, we have compared the fasting plasma insulin 
levels among the preeclamptic women and the normotensive pregnant 
women. 
 
 This study represent that, the mean value of fasting  plasma insulin 
levels among normotensive group was 2.24 µunits/ml and preeclamptic 
group was 19.9337µunits/ml and the results were comparable with that of 
studies by Chandana Tripathy et al, Shoreh et al, Lei Q et al, Solomon et 
al., as seen in the above table. 
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 There was a study conducted by Hamaski T et al 88 on 551 
normotensives and 29 preeclamptic women with fasting plasma insulin 
values of 7.3 µunits/ml vs 24.1µunits/ml respectively which was 
comparable with the results of our present study. 
 
 Soloman et al70 conducted study on 31 normotensive and 31 
preeclamptic women with fasting plasma insulin levels of 7.9 µ units/ml 
vs 13.3 µ units/ml respectively. P value of this study was 0.03, 
statistically significant. 
 
 Furthermore another study was performed by Chandana Tripathy et 
al was done among 99 normotensive and 104 preeclamptic women with 
fasting insulin levels as follows; 
 Control Group  = 6.33 + 2.83 µunits / ml (n=99) 
 Study Group  = 9 + 5 µunits(n=104) 
 P = 0.0004 statistically significant. 
 
 Shohreh et al 86 performed the study on 16 normotensive and 16 
preeclampsia women. The result in the preeclampsia women were higher 
25.3 + 1.4 µunits/ml when compared to normotensive pregnant women 
with fasting insulin value of 16.2 ± 13 µunits / ml; p=<0.01. 
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 According to Lei Q et al, study performed on 200 normotensive 
pregnant women and 33 preeclamptic women with fasting insulin value 
of 8.92 + 4.4µunits/ml vs 11.44 + 6.72 µunits/ml respectively, p=0.005. 
 
 Another study  performed by Roberts et al 39 showed that the 
fasting insulin levels among 11 normotensive and 11 preeclamptic 
women and the results were not comparable with hypothesis. The mean 
fasting insulin level was significantly lower in preeclamptic women when 
compared to control group i.e. 10mu/L vs 16.6 mu/L, p=0.016, here the 
study showed that preeclampsia was not correlated with an elevated 
insulin resistance beyond that of normal pregnancy, mutually the reverse 
is true. 
 
 To conclude, the fasting insulin levels are elevated in preeclampsia 
as compared to normotensive pregnancy and this was emphasized in the 
present study with the supportive results. 
 
 The fasting plasma insulin levels in control, mild, severe pre 
eclampsia were 2.2417 µunits/ml, 7.3571 µunits/ml and 26.4954 
µunits/ml with p value of <0.000 vhs. The results were statistically 
significant. 
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 The mean age of control group was 26.17 and study group was 
27.09 which was statistically not significant. 
 
 The mean gestational age of control group and study group was 
35.17 and 34.1 respectively which was statistically significant. 
 
 The mean BMI in the normotensive group was 24.5 and in mild 
preeclampsia, severe preeclampsia was 25.12, 24.83 respectively. BMI 
was likely more in preeclampsia group, possibly due to edema. BMI was 
not statistically significant.  
 
 However there were no studies compared the severity of the 
disease with fasting plasma insulin values, significant positive correlation 
was detected among the several studies conducted showing a higher 
fasting insulin levels among the preeclamptic women on compared to 
normotensive pregnant women with p values being statistically 
significant. 
  
Summary 
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SUMMARY 
 The present study was a prospective comparable study performed 
to determine fasting plasma insulin levels in normotensive pregnant 
women and the preeclamptic women and their relationship with the 
severity of the disorder. 
 
 Among 100 pregnant women, 30 were normotensives and 24 were 
mild preeclamptic, 46 were severe preeclamptic. 
 
 The mean age of control group was 26.17 and study group was 
27.09. 
 
 The mean gestational age of control group and study group was 
35.17 and 34.1 respectively. 
 
 The mean fasting insulin level of control, mild and severe 
preeclampsia was 2.2417µunits/ml, 7.3571µunits/ml and 
26.4954µunits/ml respectively with p value of 0.000vhs, which was 
significantly elevated as compared to normotensive group. 
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 The elevated fasting plasma insulin was appears to be directly 
proportional to the severity of the disease. According to the values of 
mild preeclampsia (7.357 µunits/ml) and severe preeclampsia (26.4954 
µunits/ml) the later group was having higher fasting insulin value when 
compared to mild preeclampsia. 
  
Conclusion 
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CONCLUSION 
 
 The present study states that pregnancy complicated by 
preeclampsia tend to be more hyperinsulinemic when compared to 
normotensive pregnant women and the study emphasized that the 
relationship between hypertension and insulin resistance is independent 
of Age, BMI. By this study we enlighten that parity, and period of 
gestation showed statistical significance. 
 
 The present study, enlighten that fasting insulin level was elevated 
in preeclamptic women when compared to normotensive pregnant 
women. In addition to that it also represent the elevated fasting insulin 
levels were directly proportional to the severity of the disease. 
 
  
Recommendation 
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RECOMMENDATION 
  
 Future studies needed in preeclamptic women about the cause of 
hyperinsulinemia which helps to improve the outcome of preeclamptic 
pregnant women. 
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Annexures 
PROFORMA 
 NAME: 
 AGE 
 OCCUPATON 
 IP NO. 
 DOA: 
 DOD 
 GPL A 
 LMP 
 EDD 
 Gestational age at the time of sampling :  
History 
 Present pregnancy-time of detection of PIH  
 Obstetric History - Past H/o PIH 
 Past History :  Any history of Chronic hypertension, Diabetes Mellitus, 
    Renal disease, Cardiac disease. 
 Family History : Any family history of PIH 
O/E 
Height :  
Weight :  
BMI :  
Pallor:  
Edema :  
Icterus:  
BP: 
  
 Systemic Examination  
Obstetric Examination  
 
Investigation : 
 Routine antenatal investigations - HB  
       HIV 
  HBsAg  
  VDRL  
  Blood group  
  Urine routine and micro  
  Random blood sugar 
Platelet Count 
RFT 
LFT 
Serum Uric Acid 
Fasting Plasma Insulin 
  
ABBREVIATIONS 
ADP  - Adenosine Diphosphate 
ALP  - Alkatine Phosphatase 
ALT  - Alanine Amino Transferase 
AST  - Aspartate Amino Transferase 
ATP  - Adenosine Triphosphate 
BMI  - Basal Metabolic Index 
BP  - Blood Pressure 
Ca++  - Calcium 
DM  - Diabetes Mellitus 
EDRF  - Endothelium Derived Relaxing Factor 
FFA  - Free Fatty Acids 
GFR  - Glomerular Filtration Rate 
Glut-2  - Glutamate -2 Carrier 
GTT  - Glucose Tolerance Test 
HDL  - High Density Lipoprotein 
IGF-1  - Insulin like Growth Factor - 1 
IgG  - Immunoglobulin G 
Igl  - Immunoglobulin I 
IRS  - Insulin Resistance Syndrome 
LDH  - Lactate Dehydrogenase 
LDL  - Low Density Lipoprotein 
  
 NHBPEP - National High Blood Pressure Education Programme 
NIDDM - Non insulin Dependent Diabetes Mellitus 
NO  - Nitric Oxide 
PAI-1  - Plasminogen Activator Inhibitor -1 
PAI-2  - Plasminogen Activator Inhibitor - 2 
PGE2  - Prostaglandin E2 
PGI2  - Prostaglandin I2 
PIH  - Pregnancy induced Hypertension 
rpm  - Rotation per minute 
SHBG  - Sex Hormone Binding Globulin 
TGS  - Triglycerides 
TXA2  - Thromboxane A2 
 
  
   
  


  
  
   
  
 
  
Sl.No Name Age DOA Ip.No POG Parity BMI Mild PE Severe 
PE
Fasting Insulin 
level
1 Mahalakshmi 26 10/6/2014 25889 37 Multi 24.18 Yes 27.03
2 Selvi 24 10/6/2014 26302 35+2 Primi 25.33 Yes 3.8
3 Poongodi 23 11/5/2014 29659 38 Primi 23.04 Yes 47.4
4 Rajeswari 31 11/7/2014 29661 32+5 Primi 19.8 Yes 24.36
5 Rekha 27 11/14/2014 30617 30 Multi 22.12 Yes 30.05
6 Bommi 25 11/15/2014 29699 38 Primi 30.09 Yes 17.81
7 Kotteeswari 30 12/2/2014 32065 33+2 Primi 24.81 Yes 9.03
8 Gayathri 26 12/9/2014 33996 36 Primi 23.26 Yes 39.2
9 Parimala 28 12/22/2014 35516 30+5 Multi 27.12 Yes 8.16
10 Manjula 29 1/5/2015 36959 29+3 Primi 22.6 Yes 28.9
11 Vijaya 35 1/5/2015 36738 37+4 Primi 24.1 Yes 32.14
12 Shanthi 29 1/12/2015 525 30 Multi 25.3 Yes 28.25
13 Alamelu 22 1/19/2015 1266 36+5 Primi 28.2 Yes 8.78
14 Maheshwari 29 1/19/2015 1307 28+3 Primi 24.6 Yes 27.08
15 Nagajothi 28 2/2/2015 2501 37 Multi 23.4 Yes 3.03
16 Soniya 27 2/6/2015 2273 31+1 Primi 26.15 Yes 43.2
17 Rajaponni 20 2/9/2015 3150 33+2 Primi 27.6 Yes 25.04
18 Sheela 34 2/9/2015 3134 32+3 Primi 26.12 Yes 27.12
19 Vijayalakshmi 32 2/27/2015 4038 33+5 Primi 20.07 Yes 10.7
20 Devi 25 3/11/2015 6197 30+1 Primi 21.42 Yes 37.84
21 Kalaiselvi 32 3/12/2015 6323 30+5 Primi 19.18 Yes 27.12
22 Geethakumari 27 3/12/2015 6247 34+3 Primi 20.09 Yes 3.8
23 Archana 21 3/13/2015 6503 37+4 Multi 21.78 Yes 8.78
24 Lakshmi 32 3/16/2015 6770 36+2 Multi 26.9 Yes 29.08
25 Avanthika 22 3/19/2015 7046 37 Primi 22.6 Yes 9.2
26 Malarvzhi 20 4/1/2015 7775 32 Primi 27.18 Yes 7.64
27 Susaimary 28 4/1/2015 8275 37+1 Primi 26.14 Yes 28.9
28 Punitha 21 4/3/2015 8484 38 Multi 23.66 Yes 7.64
29 Ambika 27 4/5/2015 8579 33+2 Primi 28.77 Yes 30.05
30 Ganga 35 6-Apr 8661 36 Primi 29.2 Yes 11.81
31 Manimegalai 21 4/6/2015 8637 30+1 Primi 22.18 Yes 24.36
32 Durga 23 4/11/2015 9499 32+2 Primi 28.1 Yes 29.75
33 Lavanya 19 4/15/2015 9705 37+6 Multi 24.6 Yes 6.54
34 Rajalakshmi 28 4/15/2015 9806 37 Primi 28.3 Yes 27.7
35 Banumathi 21 4/16/2015 9873 33+1 Primi 22.69 Yes 18.16
36 Parimala 27 4/20/2015 10295 30+3 Multi 22.16 Yes 28.01
MASTER CHART - CASES
Sl.No Name Age DOA Ip.No POG Parity BMI Mild PE Severe 
PE
Fasting Insulin 
level
37 Rubhini 34 4/21/2015 10409 29+2 Primi 25.2 Yes 7.84
38 Sheeba 33 4/21/2015 10415 36 Primi 29.4 Yes 8.2
39 Surya 24 4/26/2015 10871 32+5 Multi 28.8 Yes 17.12
40 Fathimaparveen 26 4/29/2015 11249 33 Multi 21.7 Yes 26.44
41 Ramya 30 5/1/2015 11390 37+1 Primi 23.12 Yes 23.72
42 Boomadevi 25 5/1/2015 11412 32 Primi 24.18 Yes 29.48
43 Radha 24 5/6/2015 11625 29+6 Primi 23.29 Yes 7.12
44 Sharmili 20 5/7/2015 12199 26+1 Primi 22.87 Yes 8.13
45 Chandra 22 5/10/2015 12549 30+2 Multi 22.14 Yes 9.19
46 Ammu 40 5/10/2015 12574 35 Primi 23.76 Yes 34.26
47 Krishnaveni 22 5/12/2015 12639 31+2 Primi 22.19 Yes 14.16
48 Chithradevi 28 5/14/2015 12988 27 Multi 22.18 Yes 7.33
49 Sathya 25 5/15/2015 13237 32 Multi 26.15 Yes 4.16
50 Pappy 19 5/18/2015 13569 34+5 Primi 24.86 Yes 25.22
51 Sangeetha 20 5/22/2015 14169 35+6 Primi 26.79 Yes 11.87
52 Renugadevi 29 5/27/2015 14829 30+1 Multi 24.57 Yes 29.37
53 Janagi 35 5/30/2015 15135 32 Primi 22.81 Yes 32.19
54 Gandhimathi 28 6/1/2015 15336 30+2 Primi 28.18 Yes 6.3
55 Rukmani 30 6/1/2015 15201 37+6 Multi 28.72 Yes 6.12
56 Ramya 24 6/2/2015 15380 35 Primi 27.55 Yes 14.06
57 Poongodi 27 6/2/2015 15417 36+2 Primi 26.12 Yes 6.3
58 Chandrika 34 6/2/2015 15399 33+3 Primi 26.76 Yes 27.12
59 Sarasvathi 29 6/3/2015 16001 29 Primi 24.56 Yes 8.34
60 Devaki 23 6/5/2015 16341 36+2 Primi 20.12 Yes 24.12
61 Manjula 29 6/7/2015 16569 34 Multi 26.13 Yes 28.4
62 Dhanalakshmi 32 6/9/2015 17309 37+3 Primi 25.01 Yes 25.23
63 Meenakchi 27 6/15/2015 18443 30+6 Primi 27.81 Yes 23.71
64 Shanthi 34 6/20/2015 19804 29+4 Primi 26.12 Yes 29.4
65 Punitha 22 7/1/2015 19888 36 Multi 23.88 Yes 7.12
66 Thilagavathi 24 7/5/2015 23164 35+4 Primi 26.7 Yes 25.48
67 Vijayalakshmi 29 7/6/2015 24239 37 Primi 25.12 Yes 11.87
68 Manimegalai 36 7/10/2015 25166 37+5 Primi 29.15 Yes 48.1
69 Rajamma 31 7/10/2015 25004 31 Multi 22.48 Yes 24.27
70 Ashtalakshmi 27 7/15/2015 26856 29+6 Primi 27.18 Yes 6.16
Sl.No Name Age DOA Ip.No POG Parity BMI Normotensive Mild PE Severe PE
Fasting insulin 
Level
1 Vetriselvi 24 10/6/2014 25718 37 Primi 20.6 Yes - - 0.1
2 Kasthuri 33 11/15/2014 29661 36+4 Primi 21.92 Yes - - 1.1
3 Hemalatha 21 11/30/2014 31513 35 Primi 23.26 Yes - - 0.8
4 Muthulakshmi 24 12/24/2014 33128 37+2 Primi 26.48 Yes - - 1.8
5 Thavamani 20 1/1/2015 35396 38 Primi 21.24 Yes - - 2.1
6 Geetha 18 1/30/2015 1820 30 Primi 20.06 Yes - - 0.9
7 Indhra 27 2/14/2015 3487 35+1 Multi 21.29 Yes - - 2.7
8 Gowri 27 2/15/2015 3767 37 Multi 26.34 Yes - - 6
9 Radha 30 2/28/2015 4109 36+6 Multi 20.17 Yes - - 1.6
10 Anjalai 20 3/2/2015 4136 37+4 Primi 23.26 Yes - - 0.3
11 Priyanka 32 3/6/2015 5001 38 Multi 24.12 Yes - - 2.5
12 Geethanjali 19 3/15/2015 6593 37+3 Primi 25.36 Yes - - 1.17
13 Victoriya 22 4/6/2015 8775 34 Primi 27.01 Yes - - 6.3
14 Arputhavalli 29 4/7/2015 8914 36 Multi 30.23 Yes - - 0.7
15 Radha 24 4/10/2015 9429 35 Primi 24.33 Yes - - 5.3
16 Sudha 28 4/19/2015 10200 30 Multi 27.03 Yes - - 2.4
17 Kamatchi 31 4/30/2015 11349 31+2 Primi 27.33 Yes - - 4.3
18 Nirmaladevi 33 5/2/2015 11436 33 Multi 26.22 Yes - - 1.33
19 Malinidevi 32 5/6/2015 12001 37 Primi 19.8 Yes - - 1.18
20 Asha 28 5/20/2015 13798 36+4 Multi 24.03 Yes - - 2.27
21 Baby 33 5/26/2015 14243 32+4 Multi 29.27 Yes - - 3.96
22 Sivayogasundhari 24 6/1/2015 15232 31 Primi 23.18 Yes - - 4.32
23 Savitha 26 6/5/2015 16146 33+2 Multi 24.58 Yes - - 6.14
24 Krishnapriya 29 6/10/2015 17459 35 Multi 26.22 Yes - - 0.9
25 Veerammal 22 6/15/2015 18323 37 Primi 28.16 Yes - - 0.4
26 Aishabegam 21 6/21/2015 19849 38 Multi 23.24 Yes - - 1.17
27 Sarala 19 7/1/2015 20137 34+1 Primi 28.1 Yes - - 0.53
28 Sindhuja 34 7/3/2015 22841 35+6 Multi 26.13 Yes - - 0.98
29 Chithra 31 7/3/2015 22609 36+2 Multi 28.2 Yes - - 1.1
30 Sarasvathi 24 7/15/2015 26812 37 Multi 23.1 Yes - - 2.9
MASTER CHART - CONTROL
 KEY TO MASTER CHART 
 
DOA   - Date of Admission 
IP NO.  - Inpatient Number 
POG   - Period of gestation 
BMI   - Basal Metabolic Index 
Mild PE  - Mild pre eclampsia 
Severe PE  - Severe pre eclampsia 
